Premature Labor (Tocolysis) - Pipeline Insight, 2017

Premature Labor (Tocolysis) - Pipeline Insight, 2017

DelveInsights, Premature Labor (Tocolysis)-Pipeline Insights, 2017, report provides comprehensive insights of the ongoing therapeutic research and development across Premature Labor (Tocolysis). The report provides a complete understanding of the pipeline activities covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Premature Labor (Tocolysis) by development stage, therapy type, route of administration and molecule type is also covered in the report. It also has a special feature on the inactive pipeline products in this area.

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight`s team of industry experts.

The report provides a snapshot of the pipeline development for the Premature Labor (Tocolysis) The report covers pipeline activity across the complete product development cycle i.e. clinical, pre-clinical and discovery stages for the Premature Labor (Tocolysis) The report provides pipeline product profiles which includes product description, developmental activities, licensors & collaborators and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Premature Labor (Tocolysis) The report also covers the dormant and discontinued pipeline projects related to the Premature Labor (Tocolysis)

Reasons to Buy

Establish comprehensive understanding of the pipeline activity across this Premature Labor (Tocolysis) to formulate effective R&D strategies Gather information of the emerging competitors having potentially lucrative portfolio in this space and create effective counter strategies to gain competitive advantage Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine Plot corrective measures for pipeline projects by understanding the pipeline depth and focus of Premature Labor (Tocolysis) therapeutics Devise in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope Modify the therapeutic portfolio by identifying inactive projects and understanding the factors that might have halted their progress

1. Report Introduction2. Premature Labor (Tocolysis) Overview3. Pipeline Therapeutics An Overview of Pipeline Products for Premature Labor (Tocolysis)4. Comparative Analysis5. Products in Clinical Stage5.1 Drug Name : Company Name Product Description Research and Development Product Development Activities6. Products in Pre-Clinical and Discovery Stage6.1 Drug Name : Company Name Product Description Research and Development Product Development Activities7. Therapeutic Assessment Assessment by Route of Administration Assessment by Stage and Route of Administration Assessment by Molecule Type Assessment by Stage and Molecule Type8. Inactive Products8.1 Drug Name : Company Name Product Description Research and Development Product Development ActivitiesAppendixReport MethodologyConsulting ServicesDisclaimerAbout DelveInsight